An online platform for self-management of sexual assault recovery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the effectiveness of a self-managed online cognitive behavioral therapy (CBT) platform designed for women who have experienced sexual assault. Given the significant barriers to accessing traditional CBT, particularly for this vulnerable population, the study will explore whether an online approach can provide a safe and effective alternative for managing psychological symptoms such as PTSD, insomnia, and depression. Participants will engage with the platform either independently or with therapist assistance, allowing for flexibility in treatment. The study seeks to address the lack of empirical evidence supporting self-care approaches for sexual assault survivors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Identify at least in part as a woman;
2. Be at least 18 years old;
3. Have experienced SA after the age of 12;
4. Read and speak French;
5. Have adequate Internet access; and f) Present with some post-traumatic stress symptoms (PCL-5 ≥ 10) AND at least mild depressive symptoms (PHQ-9 ≥ 5) AND/OR subclinical insomnia symptoms (ISI ≥ 8).

Exclusion Criteria :

1. Bipolar or psychotic disorder;
2. High suicidal risk, or any other condition requiring immediate intervention;
3. Already benefiting from a psychological intervention.

Where it's running

• Laval University
  Québec, Quebec, Canada Recruiting

Study contacts

• Principal investigator: Genevieve Belleville, Ph.D. — Laval University
• Study coordinator: Genevieve Belleville, Ph.D.
• Email: genevieve.belleville@psy.ulaval.ca
• Phone: 1-418-656-2131

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home use of ketamine for chronic conditions

  This study is testing whether taking ketamine at home can help people with chronic pain, depression, or PTSD feel better and improve their symptoms.

  Recruiting at 2 sites RIVER Foundation · Bigfork, Montana and 1 other locations · NCT06070766

• Examining how AMPA receptor blockade affects Ketamine's ability to reduce suicidal thoughts

  This study is testing if a medication called perampanel can improve the effects of Ketamine in reducing suicidal thoughts and depression in people with major depressive disorder, bipolar disorder, or PTSD.

  Recruiting Phase 2 Yale University · West Haven, Connecticut · NCT05786066

• Dupilumab for Major Depressive Disorder

  This study tests whether dupilumab can engage immune targets in adults with major depressive disorder to see if it can help with depressive symptoms.

  Recruiting Phase 2 Icahn School of Medicine at Mount Sinai · New York, New York · NCT07908563

• Anger, Social Thinking, and PTSD in French Veterans

  This study tests whether PTSD in former French military personnel is linked to higher anger through changes in social thinking abilities.

  Recruiting Direction Centrale du Service de Santé des Armées · Draguignan · NCT07851090

• TSND-201 treatment for PTSD in adults

  This study tests two doses of TSND-201 or placebo to see if it helps adults with PTSD.

  Recruiting at 9 sites Phase 3 Transcend Therapeutics · Denver, Colorado and 8 other locations · NCT07836647

• Accelerated vs Standard iTBS for Major Depression

  This trial tests whether giving more accelerated iTBS sessions is better tolerated and more effective than the standard schedule for adults with major depressive disorder.

  Recruiting Military Hospital 175 · Ho Chi Minh City · NCT07768397

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.